From professional translators, enterprises, web pages and freely available translation repositories.
nci common terminology criteria for adverse events
opći terminološki kriteriji za nuspojave američkog nacionalnog instituta za rak. b.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
national cancer institute (nci) common terminology criteria for adverse events
opći terminološki kriteriji za nuspojave američkog nacionalnog instituta za rak. d.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
toxicity grades are in accordance with national cancer institute common terminology criteria for adverse events.
b stupnjevi toksičnosti prikazani su u skladu s uobičajenim kriterijima za nuspojave national cancer institut-a.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
for adverse events including
događaja koji uključuju hipotenziju,
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
1 nci ctcae v 4.0 = national cancer institute common terminology criteria for adverse events version 4.0
1 nci ctcae v 4.0 = zajednički kriteriji terminologije za nuspojave nacionalnog instituta za rak verzija 4.0
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
adverse events
nuspojava
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
cns adverse events
nuspojave u sŽs-u
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
1 grading based on national cancer institute (nci) common terminology criteria for adverse events (ctcae) v3.0
1 stupnjevi se temelje na zajedničkoj terminologiji za nuspojave (ctcae) v3.0 nacionalnog instituta za rak (nci)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
adverse events including
liječenja i nuspojava.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
adverse events(s)
nuspojava
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
adverse events associated with
rifabutina može biti potrebno
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
(a) the intensity of clinical adverse events graded by the common terminology criteria for adverse events v4.0 (ctc-ae).
(a) intenzitet kliničkih nuspojava stupnjevan prema zajedničkim terminološkim kriterijima za nuspojave (common terminology criteria for adverse events, verzija 4.0, ctc-ae).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
risk of increased adverse events
rizik povećanja štetnih događaja
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
adverse events (including visual
pratiti znakovi estrogenske deficijencije.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
esco would be the common terminology.
esco bi bio zajednička terminološka osnova.
Last Update: 2017-04-06
Usage Frequency: 1
Quality:
dose modifications should be made if patients experience the following adverse reactions (grades refer to common terminology criteria for adverse events [ctcae 4.0]):
dozu je potrebno prilagoditi ako se u bolesnika pojave sljedeće nuspojave (stupnjevi su određeni prema verziji 4,0 zajedničkih terminoloških kriterija za nuspojave (engl.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
adverse events applicable to all indications:
nuspojave primjenjive na sve indikacije:
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
management of ivt injection related adverse events
praćenje nuspojava povezanih uz intravitrealno ubrizgavanje
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
adverse events of special interest (pts)
neželjeni događaji od posebnog interesa (pt)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
increase monitoring for adverse
potreban je pojačan nadzor zbog
Last Update: 2017-04-26
Usage Frequency: 1
Quality: